Cell Star

Crohn’s Disease

Crohn’s Disease is a type of Inflammatory Bowel Disease (IBD) that causes chronic inflammation of the gastrointestinal (GI) tract. Unlike Ulcerative Colitis, which is limited to the colon and rectum, Crohn’s can affect any part of the digestive tract from the mouth to the anus. It most commonly involves the end of the small intestine (ileum) and the beginning of the colon. The inflammation caused by Crohn’s is often patchy, penetrating deeper into the intestinal wall and sometimes forming strictures or.

Crohn’s Disease is a lifelong condition with periods of flare-ups and remission. While there is no cure, treatment options are available to manage symptoms, reduce inflammation, and improve quality of life.

Causes and Risk Factors

The exact cause of Crohn’s Disease remains unclear, but it is believed to result from a combination of genetic, environmental, microbial, and immunological factors.

  • Genetics: Family history significantly increases the risk.
  • Immune system: An abnormal immune response to gut microbes triggers inflammation.
  • Environmental factors: Diet, smoking, and use of certain medications (e.g., NSAIDs) may contribute.
  • Microbiome imbalance: Alterations in gut flora may influence disease onset.

Pathophysiology

Crohn’s is characterized by transmural inflammation, meaning it affects the entire thickness of the bowel wall. The inflammatory process results in:

  • Ulcers and erosions
  • Fistula formation (abnormal connections between organs)
  • Strictures (narrowing of the intestine)
  • Abscesses

The inflammation often appears in “skip lesions” – areas of diseased bowel interspersed with healthy tissue – distinguishing it from the continuous inflammation seen in Ulcerative Colitis.

Symptoms

Symptoms of Crohn’s Disease vary depending on the location and severity of the inflammation:

  • Abdominal pain and cramping
  • Chronic diarrhea, sometimes with blood
  • Weight loss and malnutrition
  • Fatigue and low energy
  • Fever
  • Delayed growth in children
  • Perianal disease: pain, drainage, skin tags, or abscesses around the anus

Extraintestinal manifestations may include:

  • Joint pain or arthritis
  • Skin rashes (e.g., erythema nodosum)
  • Eye inflammation (uveitis)
  • Liver disease (primary sclerosing cholangitis)

Diagnosis

Diagnosis is based on clinical evaluation, endoscopic findings, imaging, and histopathology.

  • Medical history and physical exam
  • Blood tests: Elevated CRP, ESR, anemia, and low albumin
  • Stool tests: Calprotectin to detect intestinal inflammation
  •  Endoscopy and colonoscopy: Visual confirmation and biopsy of inflamed areas
    • MRI and CT enterography for small bowel evaluation
    • Capsule endoscopy to visualize areas unreachable by standard scopes

Classification

Crohn’s Disease is classified by the Montreal classification based on age at diagnosis, disease location, and behavior:

  • Location: Ileal, colonic, ileocolonic, or upper GI
  • Behavior: Inflammatory, stricturing, or penetrating

Conventional Treatment

Treatment strategies aim to reduce inflammation, induce remission, and prevent complications.

Aminosalicylates (5-ASAs): Limited effectiveness in Crohn’s, mainly for mild cases

Corticosteroids: Prednisone or budesonide to control acute flares

Immunomodulators:

  • Azathioprine, 6-mercaptopurine
  • Methotrexate

Biologic therapies:

  • Anti-TNF agents (infliximab, adalimumab)
  • Anti-integrins (vedolizumab)
  • IL-12/23 inhibitors (ustekinumab)

JAK inhibitors: Used in refractory disease

Antibiotics like metronidazole and ciprofloxacin are often used for infections or abscesses.

Surgical Intervention

Surgery is often required for complications such as strictures, perforations, abscesses, or failure of medical treatment.

Types of surgeries:

  • Bowel resection
  • Strictureplasty
  • Fistula repair

Although surgery can provide symptom relief, it is not curative, and disease recurrence is common.

Stem Cell Therapy in Crohn’s Disease

Stem cell therapy is an emerging option for treatment-refractory Crohn’s, particularly for complex perianal fistulas.

Types of stem cells:

  • Mesenchymal stem cells (MSCs)
  • Hematopoietic stem cell transplantation (HSCT)

Mechanism of action:

  • Modulation of immune responses
  • Reduction of inflammation
  • Promotion of tissue repair

Clinical evidence:

  • Approved MSC therapy (e.g., darvadstrocel) is used in Europe for perianal fistulas
  • Research show improvement in healing and reduced fistula drainage

Hyperbaric Oxygen Therapy (HBOT) for Crohn’s Disease

HBOT is a supportive therapy that improves oxygen delivery to inflamed tissues and aids healing.

Mechanism:

  • Enhances tissue oxygenation
  • Reduces intestinal inflammation and edema
  • Stimulates angiogenesis and fibroblast activity
  • Accelerates wound healing in fistulas and ulcers

Clinical applications:

  • Refractory perianal disease
  • Severe flares unresponsive to medication

Evidence:

  • Studies and case reports show promising results

Nutritional and Lifestyle Management

Dietary support:

  • Enteral nutrition (liquid diet) is effective in children
  • Low-residue or low-FODMAP diets may reduce symptoms

Vitamin and mineral supplementation:

  • B12, iron, calcium, vitamin D

Smoking cessation: Smoking worsens Crohn’s and increases flare frequency

Stress management and psychological support

Monitoring and Follow-Up

  • Regular colonoscopies to assess disease activity and screen for dysplasia
  • Blood and stool markers to monitor inflammation and treatment response

Prognosis

Crohn’s Disease is a lifelong condition with variable progression. Many patients experience long periods of remission with appropriate treatment. Complications such as strictures, fistulas, and malnutrition can impact quality of life, but ongoing advancements in biologics and regenerative therapies are improving patient outcomes.

Conclusion

Crohn’s Disease is a complex autoimmune condition affecting the gastrointestinal tract with systemic implications. While traditional therapies remain foundational, regenerative approaches like stem cell therapy and HBOT offer promising new avenues, particularly for treatment-resistant cases. A personalized treatment plan combining medication, surgery, nutrition, and lifestyle management is essential for long-term control and improved quality of life.